Exemestane With Sunitinib (SUTENT®) in Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Lapatinib Plus Caelyx in Patients With Advanced Metastatic Breast Cancer Following Failure of Trastuzumab Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Non-Interventional Study With Vinorelbine ORAL in Advanced Non-Small Cell Lung Carcinoma(NSCLC) and Metastatic Breast Cancer (MBC)
- Status
- COMPLETED
- Phase
- N/A
Community Oncology Setting Cost Analysis and Disease Outcomes of Taxane Use in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
A Study of Trastuzumab Emtansine (Trastuzumab-MCC-DM1, T-DM1) in Combination With Pertuzumab Administered to Patients With Human Epidermal Growth Factor Receptor-2 (HER2)-Positive Locally Advanced or Metastatic Breast Cancer Who Have Previously Received Trastuzumab
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Capecitabine and Bevacizumab ± Vinorelbine in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Activated Allogeneic Lymphocytes for Induction Graft Versus Tumor Effect in Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma
- Status
- COMPLETED
- Phase
- NA
Efficacy Study of Single Agent Trastuzumab or Lapatinib to Treat HER2-Overexpressing Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Efficacy and Safety of IPI-504 With Trastuzumab Pretreated, Locally Advanced or Metastatic HER2 Positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Trial to Evaluate the Therapeutic Benefit of Fulvestrant in Combination With ZACTIMA in Postmenopausal Women With Bone Predominant, Hormone Receptor Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Mammaglobin-A DNA Vaccine for Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Trial of Ixabepilone in Patients With HER-2 Negative Metastatic Breast Cancer (HIT)
- Status
- TERMINATED
- Phase
- PHASE2
A Trial l of Panobinostat Given in Combination With Trastuzumab and Paclitaxel in Adult Female Patients With HER2 Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Lonafarnib in Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase IB/II Trial Combining Vinorelbine With Sorafenib as First-Line Treatment in Patients With Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study of Artesunate in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Lapatinib in Women With Metastatic Breast Cancer Who Have Failed Prior Antihormone Therapy
- Status
- TERMINATED
- Phase
- PHASE2